<img alt="" height="1" width="1" />
Salix says FDA denies approval of bowel drug
Reuters
April 28 (Reuters) - Salix Pharmaceuticals Ltd (SLXP.O) said US health regulators declined to approve its experimental drug for the treatment of a kind of inflammatory bowel disease in adults. The company said the US Food and Drug Administration issued ...
Salix drug delayed at FDA because of manufacturingBusinessWeek
FDA delays approval of Salix drugTriangle Business Journal
FDA declines to approve Salix IBD drug; Fulcrum accepts $17.6M takeover bid;FierceBiotech
MarketWatch (press release) -News & Observer -Benzinga
all 32 news articles »
More...